Balchem Stock Price, News & Analysis
Company Description
Balchem Corporation (NASDAQ: BCPC) is a global specialty ingredient manufacturer focused on health and nutrition markets. According to the company’s public disclosures and recent news releases, Balchem develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, supplying customers across a range of industries worldwide.
Balchem reports three primary business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. This segment structure is consistently described in the company’s press releases and SEC filings and forms the core of its business model.
Human Nutrition & Health
The Human Nutrition & Health segment is described by Balchem as delivering customized food and beverage ingredient systems and key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. In earlier descriptions and current news, this segment is also associated with human-grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. Through this segment, Balchem participates in markets where ingredient systems and nutrients are incorporated into finished food, beverage, dietary supplement and pharmaceutical products.
Animal Nutrition & Health
The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Company materials also associate this segment with nutritional products derived from Balchem’s microencapsulation and chelation technologies, in addition to the essential nutrient choline chloride. Balchem is identified as a producer of choline chloride in the European Union and has publicly commented on EU anti-dumping measures on choline chloride imports, underscoring the importance of this nutrient to its animal nutrition activities and to the broader food and feed supply chain.
Specialty Products
Through its Specialty Products segment, Balchem provides specialty-packaged chemicals and performance gases for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. Company communications describe this segment as including the re-packaging and distribution of performance gases and chemicals, as well as plant nutrition offerings based on chelated minerals.
Industry and Operations
Balchem is classified in the Other Animal Food Manufacturing industry within the broader Manufacturing sector. Its disclosures emphasize specialty performance ingredients, nutrients and delivery systems rather than commodity products. The company highlights microencapsulation and chelation technologies as important to its human and animal nutrition offerings, and it reports segment-level financial results for Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products in its periodic financial releases and related Form 8-K filings.
Balchem’s public statements also reference its role in supporting food and feed supply chains, particularly through choline chloride production in the EU, and its participation in health, nutrition and industrial markets through its specialty ingredients and packaged chemicals. The company’s shares trade on NASDAQ under the ticker symbol BCPC, and it files periodic and current reports with the U.S. Securities and Exchange Commission, including earnings-related Form 8-K filings.
Business Model Overview
Based on the company’s segment descriptions, Balchem’s business model centers on developing and manufacturing specialty ingredients and chemical products, then marketing them into human nutrition, animal nutrition, healthcare, agricultural and other industrial applications. Revenue is organized and reported by segment, reflecting the different end markets served: human nutrition and health applications, animal nutrition and health markets, and specialty-packaged chemicals and performance gases, along with chelated minerals for micronutrient agriculture.
Regulatory and Public Company Profile
Balchem Corporation is incorporated in Maryland and is registered with the SEC under Commission File Number 1-13648. It has reported financial results for recent quarters via Form 8-K filings that reference accompanying press releases detailing segment net sales, earnings from operations and other financial measures. The company also holds an annual meeting of shareholders, as disclosed in a Form 8-K reporting voting results on director elections, auditor ratification and advisory approval of executive compensation.
According to multiple news releases, Balchem describes itself as a global specialty ingredient manufacturer for health and nutrition markets and as a developer, manufacturer and marketer of specialty ingredients and products for a range of industries worldwide. Its combination of human nutrition, animal nutrition and specialty chemical activities positions the company within the broader manufacturing and specialty ingredients landscape.
Stock Performance
Balchem (BCPC) stock last traded at $169.03, down 0.79% from the previous close. Over the past 12 months, the stock has gained 1.5%. At a market capitalization of $5.5B, BCPC is classified as a mid-cap stock with approximately 32.0M shares outstanding.
Latest News
Balchem has 10 recent news articles, with the latest published 6 days ago. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, conferences, dividends. View all BCPC news →
SEC Filings
Balchem has filed 5 recent SEC filings, including 2 Form 4, 2 Form 8-K, 1 Form 10-K. The most recent filing was submitted on February 20, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BCPC SEC filings →
Financial Highlights
Balchem generated $1.0B in revenue over the trailing twelve months, retaining a 35.7% gross margin, operating income reached $209.3M (20.2% operating margin), and net income was $154.8M, reflecting a 14.9% net profit margin. Diluted earnings per share stood at $4.75. The company generated $216.6M in operating cash flow. With a current ratio of 2.07, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Balchem (BCPC) currently stands at 294.2 thousand shares, down 15.4% from the previous reporting period, representing 0.9% of the float. Over the past 12 months, short interest has decreased by 37.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Balchem (BCPC) currently stands at 1.8 days, down 25% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.5 to 3.9 days.
BCPC Company Profile & Sector Positioning
Balchem (BCPC) operates in the Specialty Chemicals industry within the broader Chemicals & Allied Products sector and is listed on the NASDAQ.
Investors comparing BCPC often look at related companies in the same sector, including Sensient Tech (SXT), Cabot (CBT), Element Solutions Inc (ESI), Sasol (SSL), and Axalta Coating Sys Ltd (AXTA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BCPC's relative position within its industry.